Clinical Trials Logo

Clinical Trial Summary

The aim of this phase II trial is to assess progress-free survival, local control, overall survival, safety and tolerability of SBRT to treat patients with oligometastases in esophageal squamous cell carcinoma.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03000816
Study type Interventional
Source Fudan University
Status Completed
Phase N/A
Start date April 2015
Completion date December 2020